1. Antibiotics policies in the developing world

   • A. J. Smith
   • J. K. Aronson
   • M. Thomas

   Editorial Pages: 85 - 87

2. Racemic therapeutics — ethical and regulatory aspects

   • E. J. Ariëns

   Special Article Pages: 89 - 93

3. Central and peripheral haemodynamic responses to felodipine in congestive heart failure

   • S. Capewell
   • C. G. Wathen
   • A. L. Muir

   Originals Pages: 95 - 98

4. Acute haemodynamic effects of i.v. nitrendipine in healthy subjects

   • G. Mikus
   • C. Zekorn
   • M. Eichelbaum

   Originals Pages: 99 - 103

5. Effect of lacidipine, a long-acting calcium antagonist, on hypertension and lipids: a 1 year follow-up

   • S. Soro
   • L. Aldo Ferrara

   Originals Pages: 105 - 107

6. Unaltered insulin sensitivity during calcium channel blockade with amlodipine

   • P. Ferrari
   • D. Giachino
   • G. Heynen

   Originals Pages: 109 - 113

7. Haemodynamic effects of glyceryl trinitrate following repeated application of a transdermal delivery system with a phasic release profile

   • A. Wiegand
   • R. Bonn
   • E. Jähnchen

   Originals Pages: 115 - 118

8. The effect of angiotensin II on haemodynamic and plasma noradrenaline responses to tyramine infusion in man

   • P. H. Seidelin
   • A. D. Struthers

   Originals Pages: 119 - 123

9. Reproducibility of Doppler blood flow velocity waveform measurements: study on variability within and between day and during haemodynamic intervention in normal subjects

   • G. H. Rimoy
   • N. K. Bhaskar
   • P. C. Rubin

   Originals Pages: 125 - 129

10. Intravenous infusion of iloprost in arterial occlusive disease: dose-dependent effects on skin microcirculation

    • L. Caspary
    • A. Creutzig
    • K. Alexander

    Originals Pages: 131 - 136

11. Treatment of insomnia with two benzodiazepines: a double-blind crossover study

    • K. G. Götestam
    • F. Oppöyen
    • D. Berntzen

    Originals Pages: 137 - 140

12. Inhibition of ex-vivo PAF-induced platelet aggregation by the PAF-antagonist RP 48740: relationship to plasma concentrations in healthy volunteers

    • J. L. Pinquier
    • P. Sedivy
    • A. Clucas

    Originals Pages: 141 - 145

13. Enhancement of propoxyphene bioavailability by ethanol

    • C. Girre
    • M. Hirschhorn
    • P. E. Fournier

    Originals Pages: 147 - 152

14. Urinary glucuronide excretion of fenofibric and clofibric acid glucuronides in man. Is it polymorphic?

    • H. F. Liu
    • M. Vincent-Viry
    • G. Siest

    Originals Pages: 153 - 159

15. Pharmacokinetics of halofantrine and n-desbutylhalofantrine in patients with falciparum malaria following a multiple dose regimen of halofantrine

    • J. R. Veenendaal
    • A. D. Parkinson
    • M. D. Edstein

    Originals Pages: 161 - 164

16. Fosinopril pharmacokinetics and pharmacodynamics in chronic ambulatory peritoneal dialysis patients

    • T. W. B. Gehr
    • D. A. Sica
    • K. L. Duchin

    Originals Pages: 165 - 169

17. Pharmacokinetics of intravenous bisoprolol in obese and non-obese volunteers

    • C. Le Jeunne
    • J. M. Poirier
    • F. C. Hugues

    Originals Pages: 171 - 174

18. Steady state pharmacokinetics of hydrolysed bopindolol in young and elderly men

    • D. Holmes
    • E. Nuesch
    • J. Rosenthaler

    Originals Pages: 175 - 178

19. Dose-dependent absorption and elimination of cefadroxil in man

    • T. M. Garrigues
    • U. Martin
    • L. F. Prescott

    Originals Pages: 179 - 183

20. Announcements

    Announcement Pages: 184 - 184